Headline
The latest stories from AHA Today.
The Supreme Court of the United States declined to consider AHA’s lawsuit asking the court to reverse federal appeals court decisions that threaten continued access to care for hospital outpatients in need by making significant Medicare cuts to payments for health exams at off-site clinics.
July 6 is the deadline for state and local governments to apply for grants of up to $125,000 each to develop multi-sector plans to address social determinants of health to improve chronic disease outcomes in populations experiencing health disparities and inequities.
The AHA and American Medical Association last week urged the Centers for Medicare & Medicaid Services to delay until at least Jan. 1, 2023, the deadline for physicians, hospitals and health systems to implement appropriate use criteria for advanced diagnostic imaging services, citing “the…
Commenting today on long-term care hospital provisions in the fiscal year 2022 proposed rule for the inpatient and LTCH prospective payment systems, AHA said it supports the proposals to use fiscal year 2019 claims as a basis for calculating the FY 2022 payment update; require state Medicaid…
AHA today voiced strong support for provisions in the inpatient prospective payment system proposed rule for fiscal year 2022 that would repeal the requirement that hospitals report their median payer-specific charges for Medicare Advantage organizations by Medicare severity diagnosis related group…
Avid Medical has recalled several of its medical convenience kits due to fungal contamination risk from an applicator used to sanitize skin before surgery or catheter procedures, the Food and Drug Administration announced.
The Food and Drug Administration authorized for emergency use a new drug to treat hospitalized patients receiving systemic corticosteroids who require supplemental oxygen, mechanical ventilation or extracorporeal membrane oxygenation.
U.S. health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence of the SARS-CoV-2 P.1 and B.1.351 variants, which are not susceptible to the combination therapy, the Department of Health and Human Services’ Office of…
Responding to a June 20 op-ed published in the Washington Post, AHA President and CEO Rick Pollack said the alarmist headline misrepresented the facts.
A bipartisan group in the Senate reached a deal with President Biden on a $1.2 trillion infrastructure framework that forgoes tax increases as a funding source.